97 related articles for article (PubMed ID: 20811994)
1. MAP Kinase: SUMO pathway interactions.
Yang SH; Sharrocks AD
Methods Mol Biol; 2010; 661():343-67. PubMed ID: 20811994
[TBL] [Abstract][Full Text] [Related]
2. Selective SUMO modification of cAMP-specific phosphodiesterase-4D5 (PDE4D5) regulates the functional consequences of phosphorylation by PKA and ERK.
Li X; Vadrevu S; Dunlop A; Day J; Advant N; Troeger J; Klussmann E; Jaffrey E; Hay RT; Adams DR; Houslay MD; Baillie GS
Biochem J; 2010 Apr; 428(1):55-65. PubMed ID: 20196770
[TBL] [Abstract][Full Text] [Related]
3. SUMO: a regulator of gene expression and genome integrity.
Müller S; Ledl A; Schmidt D
Oncogene; 2004 Mar; 23(11):1998-2008. PubMed ID: 15021887
[TBL] [Abstract][Full Text] [Related]
4. PIASxalpha differentially regulates the amplitudes of transcriptional responses following activation of the ERK and p38 MAPK pathways.
Yang SH; Sharrocks AD
Mol Cell; 2006 May; 22(4):477-87. PubMed ID: 16713578
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation and cell signalling.
Andreou AM; Tavernarakis N
Biotechnol J; 2009 Dec; 4(12):1740-52. PubMed ID: 19946876
[TBL] [Abstract][Full Text] [Related]
6. Regulation of MAP kinase signaling by calcium.
White CD; Sacks DB
Methods Mol Biol; 2010; 661():151-65. PubMed ID: 20811982
[TBL] [Abstract][Full Text] [Related]
7. Signalling pathways and the regulation of SUMO modification.
Guo B; Yang SH; Witty J; Sharrocks AD
Biochem Soc Trans; 2007 Dec; 35(Pt 6):1414-8. PubMed ID: 18031234
[TBL] [Abstract][Full Text] [Related]
8. Sumoylation increases HIF-1alpha stability and its transcriptional activity.
Bae SH; Jeong JW; Park JA; Kim SH; Bae MK; Choi SJ; Kim KW
Biochem Biophys Res Commun; 2004 Nov; 324(1):394-400. PubMed ID: 15465032
[TBL] [Abstract][Full Text] [Related]
9. Ribosomal protein S3 is stabilized by sumoylation.
Jang CY; Shin HS; Kim HD; Kim JW; Choi SY; Kim J
Biochem Biophys Res Commun; 2011 Oct; 414(3):523-7. PubMed ID: 21968017
[TBL] [Abstract][Full Text] [Related]
10. Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat.
Ferrer I; Blanco R; Carmona M; Puig B; Domínguez I; Viñals F
Acta Neuropathol; 2002 Apr; 103(4):391-407. PubMed ID: 11904760
[TBL] [Abstract][Full Text] [Related]
11. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation.
Bossis G; Malnou CE; Farras R; Andermarcher E; Hipskind R; Rodriguez M; Schmidt D; Muller S; Jariel-Encontre I; Piechaczyk M
Mol Cell Biol; 2005 Aug; 25(16):6964-79. PubMed ID: 16055710
[TBL] [Abstract][Full Text] [Related]
13. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
14. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma].
Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP
Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activation by combinations of NEMO SUMOylation and ATM activation stresses in the absence of DNA damage.
Wuerzberger-Davis SM; Nakamura Y; Seufzer BJ; Miyamoto S
Oncogene; 2007 Feb; 26(5):641-51. PubMed ID: 16862178
[TBL] [Abstract][Full Text] [Related]
16. Analysis of androgen receptor SUMOylation.
Rytinki MM; Kaikkonen S; Sutinen P; Palvimo JJ
Methods Mol Biol; 2011; 776():183-97. PubMed ID: 21796528
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction inhibitors in cellular function.
Fu M; Wang C; Zhang X; Pestell RG
Methods Mol Biol; 2004; 284():15-36. PubMed ID: 15173606
[TBL] [Abstract][Full Text] [Related]
18. Dynamic interplay of the SUMO and ERK pathways in regulating Elk-1 transcriptional activity.
Yang SH; Jaffray E; Hay RT; Sharrocks AD
Mol Cell; 2003 Jul; 12(1):63-74. PubMed ID: 12887893
[TBL] [Abstract][Full Text] [Related]
19. SUMO promotes HDAC-mediated transcriptional repression.
Yang SH; Sharrocks AD
Mol Cell; 2004 Feb; 13(4):611-7. PubMed ID: 14992729
[TBL] [Abstract][Full Text] [Related]
20. Extracellular signal-regulated kinase mitogen-activated protein kinase signaling initiates a dynamic interplay between sumoylation and ubiquitination to regulate the activity of the transcriptional activator PEA3.
Guo B; Sharrocks AD
Mol Cell Biol; 2009 Jun; 29(11):3204-18. PubMed ID: 19307308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
